Skip to main content

Policy

Policy/Advocacy
The New York Association of Addiction Services and Professionals and the Coalition for Behavioral Health on Thursday announced a partnership to boost their addiction treatment and behavioral health advocacy efforts.
Policy
Ron Manderscheid, Executive Director, NACBHDD and NARMH
Identification of a more rapid pathway for research on cannabinoids and a separate pathway for research on over-the-counter products were among the topics discussed by Summit speakers.
New York Gov. Andrew Cuomo has opted to prohibit prior authorization requirements for opioid use disorder medications under private insurance, but not under Medicaid.
Policy
Ron Manderscheid, Executive Director, NACBHDD and NARMH
We will face difficult choices around personal rights, social justice and life chances in the new year.
Behavioral Healthcare Executive
Ron Manderscheid, Executive Director, NACBHDD and NARMH
Panelists say CBD is a critical medicine for treating potentially very severe disorders, but more regulation for non-medical CBD products is a must.
Behavioral Healthcare Executive
Mark Covall, president and CEO of the National Association for Behavioral Healthcare, says more stringent enforcement of existing parity laws and increased dialogue with payers will be trends to watch in 2020.
Behavioral Healthcare Executive
A Milliman study released Wednesday shows a growing disparity in network use and provider reimbursement for employees and their families seeking treatment for mental health and addiction versus those seeking treatment for physical health conditions.
Perspectives
Our industry needs a common voice, not for industrywide lobbying or sales promotion, but to elucidate our tremendous value.
Behavioral Healthcare Executive
Mothers Against Prescription Drug Abuse will present its first Humanitarian Award to U.S. Rep. Hal Rogers of Kentucky for his work on various initiatives in response to the opioid epidemic.
Behavioral Healthcare Executive
H. Steven Moffic
Speaking out about political leadership can be costly for mental healthcare professionals. Yet, in this time of escalating political polarization, mental health professionals and organizations do have the ethical challenge of what, if anything, to say and do about our current situation.

Behavioral Healthcare Executive
The first supervised injection facility in the United States is one step closer to opening after a U.S. district judge ruled that a Philadelphia not-for-profit’s project does not violate federal drug laws.
Back to Top